Alkermes (ALKS) Leases (2011 - 2026)
Alkermes' (ALKS) quarterly Leases came in at $78.2 million in Q1 2026, down 5.05% year-on-year from $82.4 million in Q1 2025, and up 1.35% on a QoQ basis from $77.2 million in Q4 2025.
Alkermes (ALKS) Leases (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 10 years of Leases data on file, last reported at $78.2 million in Q1 2026.
- On a quarterly basis, Leases fell 5.05% year-over-year to $78.2 million in Q1 2026; TTM through Mar 2026 was $78.2 million, a 5.05% decrease from a year earlier, with the FY2025 full-year figure at $77.2 million, down 8.35% from the prior year.
- Leases for Q1 2026 stood at $78.2 million, up from $77.2 million in the prior quarter.
- Over the last five years, Leases for ALKS reached as high as $115.3 million in Q1 2022 and fell as low as $77.2 million in Q4 2025.
- Historically, Leases has averaged $93.5 million across 5 years, with a median of $89.7 million in 2024.
- Across the five-year window, Leases retreated 3.24% in 2023 and retreated 19.63% in 2024, its largest moves.
- Year by year, Leases stood at $97.5 million in 2022, then declined by 6.23% to $91.5 million in 2023, then dropped by 7.89% to $84.2 million in 2024, then declined by 8.35% to $77.2 million in 2025, then increased by 1.35% to $78.2 million in 2026.
- Per Business Quant data, the three most recent Leases figures were $78.2 million in Q1 2026, $77.2 million in Q4 2025, and $79.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 335.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 282.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 253.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 447.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 78.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.25 Mn |
| Dec 31, 2025 | 77.21 Mn |
| Sep 30, 2025 | 79.13 Mn |
| Jun 30, 2025 | 80.53 Mn |
| Mar 31, 2025 | 82.41 Mn |
| Dec 31, 2024 | 84.25 Mn |
| Sep 30, 2024 | 86.08 Mn |
| Jun 30, 2024 | 87.89 Mn |
| Mar 31, 2024 | 89.68 Mn |
| Dec 31, 2023 | 91.46 Mn |
| Sep 30, 2023 | 103.17 Mn |
| Jun 30, 2023 | 107.36 Mn |
| Mar 31, 2023 | 111.59 Mn |
| Dec 31, 2022 | 97.54 Mn |
| Sep 30, 2022 | 106.98 Mn |
| Jun 30, 2022 | 111.12 Mn |
| Mar 31, 2022 | 115.32 Mn |
| Dec 31, 2021 | 115.63 Mn |
| Sep 30, 2021 | 118.76 Mn |
| Jun 30, 2021 | 123.01 Mn |